News

Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working.

Researchers have developed a process to bioengineer heparin, the world’s most widely used blood thinner, which is currently derived from pig intestines.

Human sweat contains a protein that may protect against Lyme disease, according to a study. About one-third of the population carries a genetic variant of this protein that is associated with Lyme disease in genome-wide association studies.

The same “anti-hunger” molecule stimulated by vigorous exercise can also be produced by the common diabetes drug metformin, according to a new study from Stanford University.

Researchers have developed a microbial fermentation method to produce galantamine with the help of artificial intelligence (AI) and biosensors.

A research team has discovered that exosomes derived from γδ-T cells not only have direct anti-tumour effects but also, when developed into a tumour vaccine, can effectively induce a tumour-specific immune response.

A project aiming to use food by-products to produce antimicrobial drugs from bacteria has been awarded a £1.1 million grant to help antimicrobial production to be more cost-effective and sustainable.

Just days after a single treatment of a new cell therapy, three glioblastoma patients experienced dramatic reductions in their tumors.

Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain cancer.

Progesterone has been shown to help prevent preterm birth in women with a short cervix.